Research advances on related molecules and genes affecting the efficacy of gemcitabine for pancreatic cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 501-504, 2012.
Article
in Chinese
| WPRIM
| ID: wpr-429164
ABSTRACT
Pancreatic cancer normally is lethal and difficult to treat.Recently,although chemotherapy drugs such as gemcitabine for the treatment achieved a certain effect, but the survival rate has not improved significantly. Over the past decade, a large number of studies that aimed to implicated in pancreatic tumor gemcitabine metabolism and resistance mechanisms. Recent data show that it is a great value for predicting efficacy in the treatment of pancreatic cancer with gemcitabine by detecting pancreatic cancer -related molecules and genes, especially in the field of individual therapy. This review describes advances in the studies of related molecules and genes affecting the efficacy of gemcitabine for pancreatic cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS